Healthy Magazine Healthy RGV Issue 117 - Page 14

HEALTHY LIFESTYLE · AUGUST 2018 TREATMENTS PUTTING CHEMO IN THE BACKSEAT CAR-T, or Chimeric Antigen Receptor T cell therapy, is a personalized therapy in which a patient’s own blood cells are removed and reengineered in a lab to engage the immune system to attack cancer. The Food and Drug Administration first approved the CAR-T therapy in 2017 for specific types of lymphoma and leukemia after promising results during clinical trials. Earlier this year, Texas Oncology–Baylor Charles A. Sammons Cancer, in collaboration with Baylor University Medical Center, became the second facility in the state to provide groundbreaking FDA-approved CAR-T therapy for large B-cell lymphoma. Is chemotherapy for cancer treatment going the way of 8-track tapes and rotary dial phones? While that overstates the situation, the trend away from chemo is clear as cancer care is c